Literature DB >> 1962978

Integrated defective replication units of hepatitis B virus.

P Schranz1, H Zentgraf, C H Schröder.   

Abstract

Stable transformants of the human hepatoma cell line HepG2 were established that constitutively transcribe a DNA unit consisting of a stretch of hepatitis B virus DNA and of nonviral DNA conferring resistance to neomycin. Previously it had been shown that upon cotransfection of such transformants with replication-competent HBV DNA, transcripts of such units become reverse transcribed, demonstrating that DNA constructs can function as defective replication units. Transformed cell lines stably transcribing the defective replication units could be shown to use the transcriptional starts for the viral pregenome and for the large core antigen at a ratio of 9:1. Upon the induction of replicative processes in the transformed cells by transfection with replication-competent wild type (wt) DNA, defective pregenomes transcribed from the integrated state became included in the pool of replicating nucleic acids.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1962978     DOI: 10.1007/bf00570031

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  18 in total

1.  5'-terminal sequences influence the segregation of ground squirrel hepatitis virus RNAs into polyribosomes and viral core particles.

Authors:  G H Enders; D Ganem; H E Varmus
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

2.  Defective replication units of hepatitis B virus.

Authors:  P Schranz; H Zentgraf; I F Loncarević; M Niepmann; C H Schröder
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

Review 3.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

4.  Cloned HBV DNA causes hepatitis in chimpanzees.

Authors:  H Will; R Cattaneo; H G Koch; G Darai; H Schaller; H Schellekens; P M van Eerd; F Deinhardt
Journal:  Nature       Date:  1982-10-21       Impact factor: 49.962

5.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Replication of hepatitis B virus in a hepatocellular carcinoma.

Authors:  I F Loncarević; P Schranz; H Zentgraf; X H Liang; G Herrmann; Z Y Tang; C H Schröder
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

7.  Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome.

Authors:  H Farza; M Hadchouel; J Scotto; P Tiollais; C Babinet; C Pourcel
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

9.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

10.  Defective mutants of hepatitis B virus in the circulation of symptom-free carriers.

Authors:  H Okamoto; F Tsuda; M Mayumi
Journal:  Jpn J Exp Med       Date:  1987-08
View more
  2 in total

1.  A composite polyadenylation signal with TATA box function.

Authors:  N Paran; A Ori; I Haviv; Y Shaul
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.

Authors:  Scott Preiss; Margaret Littlejohn; Peter Angus; Alex Thompson; Paul Desmond; Sharon R Lewin; Joe Sasadeusz; Gail Matthews; Gregory J Dore; Tim Shaw; Vitini Sozzi; Lilly Yuen; George Lau; Anna Ayres; Chloe Thio; Anchalee Avihingsanon; Kiat Ruxrungtham; Stephen Locarnini; Peter A Revill
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.